Skip to main content

Advertisement

Log in

Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson’s disease

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background

The well known global improvement of quality of life (QoL) after bilateral high frequency chronic deep brain stimulation of the subthalamic nucleus (STN DBS) in Parkinson’s disease (PD) is in contrast to behavioral disturbances as observed after surgery. Indeed the impact of DBS on physical versus mental aspects of QoL in PD remains unknown.

Objective

To assess the influence of bilateral STN DBS on physical versus mental aspects of QoL in Parkinson’s disease.

Methods

The results of 27 patients for the Unified Parkinson’s disease Rating Scale (UPDRS), Parkinson’s Disease Questionnaire 39 (PDQ39) and Short Form 36 health survey questionnaire (SF36) were compared before surgery and after 12 months of bilateral STN DBS.

Results

Comparing off–dopa conditions before versus 12 months after surgery, both UPDRS part II and part III significantly improved: 32.6% and 52%, respectively. UPDRS part I scores did not change significantly at 12 months. As for PDQ39, the global score significantly improved after surgery (21.1 %) as did four subscores: mobility (25.6 %), activity of daily living (34.5 %), stigma (40.1 %) and bodily discomfort (30 %). Three PDQ39 subscores, however, showed no significant changes: emotional well–being (10.7 %), social support (3.2%) and cognition (8.5 %) and one item even worsened: communication (–7.7 %). In SF36, only physical items significantly improved.

Conclusion

Using clinician’s based rating scale, bilateral STN DBS showed significant improvement in PD patients at 12 month follow up. However, using patient’s self–assessment scales, the clinical benefit of STN DBS was more subtle: physical items of QoL significantly improved, whereas mental items such as emotional well–being, social support, cognition and communication showed no improvement. Our results are suggestive of a dissociation of motor and non–motor symptoms control after bilateral STN DBS in PD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Berney A, Vingerhoets F, Perrin A, Guex P, Villemure JG, Burkhard PR, Benkelfat C, Ghika J (2002) Effect on mood of subthalamic DBS for Parkinson’s disease: a consecutive series of 24 patients. Neurology 59:1427–1429

    CAS  PubMed  Google Scholar 

  2. CAPIT Committee: Langston JW, Widner H,Goetz CG, Brooks D, Fahn S, Freeman T,Watts R (1992) Core Assessment Program for Intracerebral Transplantations. Mov Disord 7:2–13

    PubMed  Google Scholar 

  3. Damiano AM, Snyder C, Strausser B, Willian MK (1999) A review of healthrelated quality of life concepts and measures for Parkinson’s disease. Qual Life Res 8(3):235–243

    CAS  PubMed  Google Scholar 

  4. Fahn S, Elton RL,members of UPDRS development committee (1987) Unified Parkinson Disease Rating Scale. In: Fahn S,Marsden CD, Calne DB (eds) Recent Developments in Parkinson’s disease. Florham Park, NJ: Macmillan Health Care Information, pp 153–164

  5. Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752

    CAS  PubMed  Google Scholar 

  6. Houeto JL, Damier P, Bejjani PB, Staedler C, Bonnet AM, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y (2000) Subthalamic stimulation in Parkinson’s disease. A multidisciplinary approach. Arch Neurol 57:461–465

    CAS  PubMed  Google Scholar 

  7. Just H, Ostergaard K (2002) Healthrelated quality of life in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord 17(3):539–545

    PubMed  Google Scholar 

  8. Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, Lang AE (1998) Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology 51:850–855

    CAS  PubMed  Google Scholar 

  9. Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK (2000) The quality of life in Parkinson’s disease. Mov Disord 15:216–223

    CAS  PubMed  Google Scholar 

  10. Lagrange E, Krack P, Moro E, Ardouin C, Van Blercom N, Chabardes S, Benabid AL, Pollak P (2002) Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 59:1976–1978

    CAS  PubMed  Google Scholar 

  11. Lezcano E, Gomez-Esteban JC, Zarranz JJ, Lambarri I, Madoz P, Bilbao G, Pomposo I, Garibi J (2004) Improvement in quality of life in patients with advanced Parkinson’s disease following bilateral deep-brain stimulation in subthalamic nucleus. Eur J Neurol 141(7):451–454

    Google Scholar 

  12. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 339:1105–1111

    CAS  PubMed  Google Scholar 

  13. Limousin P, Pollak P, Benazzouz A (1995) Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345:91–95

    CAS  PubMed  Google Scholar 

  14. Lozano AM, Lang AE, Galvez-Jimenez N, Miyasaki J, Duff J, Hutchinson WD, Drostovsky JO (1995) Effect of GPi pallidotomy on motor function in Parkinson’s disease. Lancet 25: 1383–1397

    Google Scholar 

  15. Martínez-Martín P (1998) An introduction to the concept of quality of life in Parkinson’s disease. J Neurol 245 (Suppl 1):2–5

    Google Scholar 

  16. Martínez-Martín P,Valldeoriola F, Tolosa E, Pilleri M, Molinuevo JL, Rumià J, Ferrer E (2002) Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord 17(2):372–377

    PubMed  Google Scholar 

  17. Mattis S (1988) Dementia rating scale. Resources Inc.Odessa, FL: Psychological Assessment

  18. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389

    CAS  PubMed  Google Scholar 

  19. Moro E, Scerrati M, Romito LMA, Roselli R, Tonali P, Albanese A (1999) Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease. Neurology 53:85–90

    CAS  PubMed  Google Scholar 

  20. Patel NK, Plaha P, O’Sullivan K, Mc-Carter R, Heywood P, Gill SS (2003) MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:1631–1637

    CAS  PubMed  Google Scholar 

  21. Peto V, Fitzpatrick R, Jenkinson C (1997) Self-reported health status and access to health services in a community sample with Parkinson’s disease. Disabil Rehab 19:97–103

    CAS  Google Scholar 

  22. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248

    CAS  PubMed  Google Scholar 

  23. Rubenstein LM, Voelker MD, Chrischilles EA, Glenn DC, Wallace RB, Rodnitzky RL (1998) The usefulness of the functional status questionnaire and medical outcomes study short form in Parkinson’s disease research. Qual Life Res 7:279–290

    CAS  PubMed  Google Scholar 

  24. Saint-Cyr JA, Trépanier LL, Lumar R, Lozano AM, Lang E (2000) Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain 123:2091–2108

    PubMed  Google Scholar 

  25. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M (2003) Young-versus older-onset Parkinson’s disease: impact of disease and psychosocial consequences. Mov Disord 18(11): 1250–1256

    PubMed  Google Scholar 

  26. Talairach J, David M, Tournoux P, Corredor H, Kvasina T (1957) Atlas d’anatomie stéréotaxique des noyaux gris centraux. Masson, Paris

  27. Tröster AI, Fields JA, Wilkinson S, Pahwa R, Koller WC, Lyons KE (2003) Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg 80(1–4):43–47

    PubMed  Google Scholar 

  28. Tröster AI, Lyons KE, Straits-Tröster K (1999) Determinants of health related quality of life changes in Parkinson’s disease. In:Martínez-Martín P, Koller WC (eds) Quality of life in Parkinson’s disease. Barcelona: ALEU, SA, pp 55–77

  29. Ware JE, Kosinski M, Keller SD (1995) SF36 physical and mental health summary scales: a user manual. Boston, Massachusetts: Health Institute, New England Medical Center

  30. Ware JE (1987) Standards for validating health measures: definition and content. J Chronic Dis 40:473–480

    PubMed  Google Scholar 

  31. Ware JE (1996) The SF36 Health Survey. Quality of life and Pharmacoeconomics in Clinical Trials, Second Edition. Lippincott-Raven Publishers Philadelphia 34:337–345

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Verin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drapier, S., Raoul, S., Drapier, D. et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson’s disease. J Neurol 252, 583–588 (2005). https://doi.org/10.1007/s00415-005-0704-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0704-4

Key words

Navigation